AJP - Renal Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol (April 1, 2009). doi:10.1152/ajprenal.90428.2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
296/6/F1323    most recent
90428.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huang, S.
Right arrow Articles by Chen, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huang, S.
Right arrow Articles by Chen, R.
Submitted on July 22, 2008
Revised on March 27, 2009
Accepted on March 28, 2009

Aldosterone-induced mesangial cell proliferation is mediated by EGF receptor transactivation

Songming Huang1*, Aihua Zhang2, Guixia Ding1, and Ronghua Chen

1 Nanjing Medical University
2 Nanjing Children's Hospital

* To whom correspondence should be addressed. E-mail: rhchen{at}njmu.edu.cn.

Aldosterone (ALDO) stimulates glomerular mesangial cell (MC) proliferation, in part, through an ERK1/2-dependent pathway. In this study, we examined whether ALDO activation of ERK1/2 in MC is mediated through redox-dependent EGFR transactivation, as well as the involvement of other signaling mechanisms in ALDO-induced MC proliferation. ALDO increased human MC proliferation, as determined by [3H]thymidine incorporation and cell counts. This increase in proliferation was blocked by inhibition of the mineralocorticoid receptor (MR). We examined the ability of ALDO to activate both the Ras/MAPK and the PI3K signaling pathways. ALDO increased Ki-RasA and Ki-RasA:GTP levels, and sequentially phosphorylated c-Raf, MAPK kinase (MEK1/2), and ERK1/2. Ki-RasA siRNA, the c-Raf inhibitor GW5074, and the MEK1/2 inhibitor PD98059 reduced ALDO-induced cell proliferation by 65%. ALDO also increased phosphorylation of PI3K, Akt, mammalian target of rapamycin (mTOR), and the 70 kDa ribosomal S6 kinase (p70S6K1). Inhibition of PI3K pathways by the selective PI3K inhibitor LY 294002, an Akt inhibitor, or the mTOR inhibitor rapamycin reduced cell proliferation by 51%. Combining LY 294002 and PD98059 completely blocked ALDO-induced MC proliferation. Pretreatment with EGFR antagonist AG1478 inhibited MC proliferation, as well as the activation of Ras/MAPK and PI3K/Akt, suggesting that Ras/MAPK and PI3K/Akt activation occur downstream of EGFR activation. Finally, we examined the role of reactive oxygen species (ROS) in ALDO-induced transactivation of EGFR. ALDO-induced ROS was predominantly generated by mitochondira. Pretreatment with the anti-oxidant N-Acetyl-L-cysteine (NAC), catalase, superoxide dismutase (SOD), mitochondrial respiratory chain complex I inhibitor rotenone (ROT), NADPH oxidase inhibitor apocynin and DPI significantly inhibited ALDO-stimulated MC proliferation as well as EGFR transactivation. However, ROT reduced MC proliferation more potently than apocynin and DPI. In conclusion, ALDO stimulated cell proliferation through MR-mediated, redox-sensitive EGFR transactivation, which was dependent on the Ki-RasA/c-Raf/MEK/ERK and PI3K/Akt/mTOR/p70S6K1 signaling pathways in human MCs.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.